GTS SECURITIES LLC
Broker-DealerPosition in SABS — SAB Biotherapeutics, Inc.
CIK 1452765
NEW YORK, NY
Position in SABS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
41,301
+0.7% QoQ
Ownership
0.045%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SABS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GTS SECURITIES LLC holds $5,249,889 across 19 Biotechnology names. SABS ranks #18 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
1,164 | $1,079,924 | |
| 2 | GMAB |
Genmab A/S
|
32,116 | $882,226 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,060 | $526,533 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,452 | $437,095 | |
| 5 | TBPH |
Theravance Biopharma, Inc.
|
25,320 | $430,440 | |
| 6 | TLX |
Telix Pharmaceuticals Ltd
|
35,537 | $409,741 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
626 | $390,336 | |
| 8 | BHVN |
Biohaven Ltd.
|
16,988 | $252,781 |
All Filings in SABS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 SABSW | — | 41,301 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 SABSW | — | 41,001 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 SABSW | — | 41,101 | Shares | Defined | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||